Search

Simulations Plus Inc

Cerrado

SectorSanidad

18.33 -0.11

Resumen

Variación precio

24h

Actual

Mínimo

18.27

Máximo

18.37

Métricas clave

By Trading Economics

Ingresos

-960K

3.6M

Ventas

-2.4M

22M

P/B

Media del Sector

45.525

62.58

BPA

0.3

Margen de beneficios

16.335

Empleados

212

EBITDA

-6.3M

1.1M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-5.48% downside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-2.9M

368M

Apertura anterior

18.44

Cierre anterior

18.33

Noticias sobre sentimiento de mercado

By Acuity

73%

27%

299 / 340 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 jul 2026, 10:46 UTC

Social Media
News

Knight-Swift Transportation reported strong Q2 results, with revenue of $2.1 billion and adjusted EPS of $0.63, but shares are lower in pre-market trading.

23 jul 2026, 10:46 UTC

Social Media
News
Correlated Moves

Northrop Grumman Corp secured a $1.2 billion contract for E-2D aircraft production, boosting shares in pre-market trading amid positive investor sentiment.

23 jul 2026, 10:46 UTC

News

Blackstone Inc has launched two hybrid investment funds to expand access to alternative investments. Shares are trading higher since Wednesday's close, despite earlier losses.

23 jul 2026, 10:46 UTC

News

Barclays lowered Pegasystems' price target to $39.00 from $48.00, maintaining an Overweight rating. Shares are trading lower in pre-market hours.

23 jul 2026, 10:46 UTC

News
Social Media

Intel is finalizing long-term purchase commitments for data-center processors in China, driven by AI demand. Shares are higher in pre-market trading ahead of earnings.

23 jul 2026, 10:46 UTC

News

Geopolitical tensions are impacting the US 10Y Treasury Bond Index. As a result, Vanguard Total Bond Market ETF is trading roughly flat during pre-market hours.

23 jul 2026, 10:46 UTC

News

Community Health Systems shares lower in pre-market after Barclays cut the price target to $2.50, following a decline in net income and revenues.

23 jul 2026, 10:42 UTC

News

Coca-Cola recognized as a top dividend stock, offering a quarterly dividend of $0.53 per share. Shares are higher in pre-market trading.

23 jul 2026, 10:36 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is slightly higher in pre-market trading, supported by strong performances from key holdings, despite broader market caution ahead of the ECB decision.

23 jul 2026, 10:36 UTC

News

Schlumberger NV reports $8.72 billion in quarterly revenue, down 6.3% year-over-year. Shares advance in pre-market trading, supported by positive sector sentiment.

23 jul 2026, 10:36 UTC

Social Media
News

General Motors shares are higher in pre-market trading following strong Q2 results and price target increases from TD Cowen and Goldman Sachs.

23 jul 2026, 10:32 UTC

Social Media
News

Hewlett Packard Enterprise shares are higher in pre-market trading, supported by strong investor interest in AI infrastructure and positive sector sentiment following Dell's gains.

23 jul 2026, 10:26 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF trades roughly flat in pre-market hours as major tech firms prepare to report quarterly earnings, influencing investor focus on AI and cloud growth.

23 jul 2026, 10:26 UTC

News

Fortinet Inc. has been named Intel's first external customer for its foundry business, producing the SP6 security chip. Shares are higher in pre-market hours.

23 jul 2026, 10:26 UTC

News
Correlated Moves

ConocoPhillips shares are higher in pre-market trading, reflecting a positive response to rising WTI crude prices amid escalating Middle East tensions.

23 jul 2026, 10:26 UTC

News

Nasdaq Inc is advancing in pre-market trading as it prepares to implement new delisting rules for underperforming microcap companies following SEC approval.

23 jul 2026, 10:16 UTC

News

PagSeguro Digital shares are lower in pre-market trading following Jefferies' Hold rating and price target of $10.40, after closing at $9.67.

23 jul 2026, 10:16 UTC

News
Event

Arrowhead Pharmaceuticals shares rise in pre-market trading, building on Wednesday's gains after positive drug trial results and a price target increase to $115 from $90.

23 jul 2026, 10:16 UTC

News

DigitalOcean Holdings sees strong demand for AI data centers, with $800 million in remaining performance obligations. Shares are higher in pre-market trading.

23 jul 2026, 10:16 UTC

News

American Electric Power shares are lower in pre-market trading amid ongoing performance weakness, despite the appointment of two new board members.

23 jul 2026, 10:16 UTC

Social Media
News

Netflix Inc. shares are higher in pre-market trading, supported by strong Movies & Entertainment sector performance and robust EBITDA of $8.66 billion.

23 jul 2026, 10:16 UTC

News
Social Media

Advanced Micro Devices is finalizing long-term CPU commitments in China, driven by AI demand. Shares are higher in pre-market trading amid these developments.

23 jul 2026, 10:16 UTC

Social Media
News
Correlated Moves

Apple Inc shares are lower in pre-market trading amid a broader market downturn and challenges in foldable iPhone production, though the launch schedule remains on track.

23 jul 2026, 10:11 UTC

News

Autodesk shares rise in pre-market after Guggenheim Buy rating.

23 jul 2026, 10:11 UTC

News

Southwest Airlines shares are lower in pre-market trading after the company issued third-quarter guidance below consensus and revised full-year EPS expectations downward.

23 jul 2026, 10:11 UTC

News

American Airlines shares are trading lower in pre-market hours as higher jet fuel costs weigh on earnings projections ahead of upcoming results.

23 jul 2026, 10:11 UTC

Social Media
News

Kinder Morgan shares are higher in pre-market trading following strong second-quarter results, including record net income of $867 million and a dividend increase to $0.2975.

23 jul 2026, 10:11 UTC

News

Teledyne Technologies announced a five-year partnership with the Royal National Lifeboat Institution to enhance lifeboat technology. Needham raised its price target to $750.

23 jul 2026, 10:06 UTC

Social Media
News

Micron Technology shares higher in pre-market trading following a Motley Fool prediction of $1,400 by 2027, citing strong revenue growth and strategic agreements.

23 jul 2026, 10:06 UTC

News

EQT Corp's stock rises in pre-market trading after raising full-year natural gas production guidance and securing long-term supply agreements.

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

-5.48% descenso

Estimación a 12 Meses

Media 17.25 USD  -5.48%

Máximo 18.5 USD

Mínimo 16 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

0

Comprar

4

Mantener

0

Vender

Sentimiento

By Acuity

299 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat